While manipulating the PTEN–miRNA–PTENP1 axis holds great promise for the future of cancer therapies, our knowledge of the mechanisms of post-transcriptional regulation of PTEN, the various competing components, and the complexities of their interactions needs further study to allow this to become a future reality. Here, PTENP1 is linked to cancer.